RecruitingPhase 1NCT07215884

Dopamine and Sensorimotor Function in Stuttering

Sponsor

University of California, San Francisco

Enrollment

25 participants

Start Date

Sep 30, 2025

Study Type

INTERVENTIONAL

Conditions

Stuttering, Adult

Summary

This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Aripiprazole 10 MG and a drug called Placebo for people with stuttering, adult. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.